SOLUBLE KIT RECEPTOR IN HUMAN SERUM

被引:57
作者
WYPYCH, J [1 ]
BENNETT, LG [1 ]
SCHWARTZ, MG [1 ]
CLOGSTON, CL [1 ]
LU, HS [1 ]
BROUDY, VC [1 ]
BARTLEY, TD [1 ]
PARKER, VP [1 ]
LANGLEY, KE [1 ]
机构
[1] UNIV WASHINGTON,DEPT MED,DIV HEMATOL,SEATTLE,WA
关键词
D O I
10.1182/blood.V85.1.66.bloodjournal85166
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
c-kit encodes the transmembrane receptor tyrosine kinase (Kit) for the recently described ligand stem cell factor (SCF). We have developed an enzyme-linked immunosorbent assay for measuring soluble human Kit and we have used the assay to show high levels of soluble Kit in human serum. The distribution of soluble Kit levels was investigated among 112 normal human serum donors. The mean serum level (+/-SD) was found to be 324 +/- 105 ng/mL with the values falling between 163 ng/mL and 788 ng/mL. No correlation between soluble Kit levels and the sexes or ages of the donors was found. partial purification using immunoaffinity chromatography allowed us to characterize the soluble Kit from pooled human serum. Antibodies generated to a 497-amino acid recombinant human soluble Kit corresponding to the N-terminal extracellular domain of the receptor recognized the serum-derived soluble Kit by immunoblotting. We found that the serum-derived soluble Kit is glycosylated, with mostly N-linked but also O-linked carbohydrate, and with terminal sialic acid residues. When compared with the recombinant human soluble Kit, the serum-derived material was similar both in size and glycosylation pattern. CNBr cleavage of the isolated serum-derived material followed by amino terminal sequencing confirmed the presence of five peptides expected for the extracellular portion of the Kit molecule. The immunoaffinity purified serum-derived soluble Kit inhibited binding of [I-125]SCF to membrane-bound receptor in an in vitro assay. These results indicate that soluble Kit could modulate the activity and functions of SCF in vivo. (C) 1995 by The American Society of Hematology.
引用
收藏
页码:66 / 73
页数:8
相关论文
共 70 条
[1]   ABSENCE OF ABNORMALITIES OF C-KIT OR ITS LIGAND IN 2 PATIENTS WITH DIAMOND-BLACKFAN ANEMIA [J].
ABKOWITZ, JL ;
BROUDY, VC ;
BENNETT, LG ;
ZSEBO, KM ;
MARTIN, FH .
BLOOD, 1992, 79 (01) :25-28
[2]  
ALAI M, 1992, J BIOL CHEM, V267, P18021
[3]   MOLECULAR-CLONING OF MAST-CELL GROWTH-FACTOR, A HEMATOPOIETIN THAT IS ACTIVE IN BOTH MEMBRANE-BOUND AND SOLUBLE FORMS [J].
ANDERSON, DM ;
LYMAN, SD ;
BAIRD, A ;
WIGNALL, JM ;
EISENMAN, J ;
RAUCH, C ;
MARCH, CJ ;
BOSWELL, HS ;
GIMPEL, SD ;
COSMAN, D ;
WILLIAMS, DE .
CELL, 1990, 63 (01) :235-243
[4]  
ANDRE C, 1992, ONCOGENE, V7, P685
[5]   A NEW ACUTE TRANSFORMING FELINE RETROVIRUS AND RELATIONSHIP OF ITS ONCOGENE V-KIT WITH THE PROTEIN-KINASE GENE FAMILY [J].
BESMER, P ;
MURPHY, JE ;
GEORGE, PC ;
QIU, F ;
BERGOLD, PJ ;
LEDERMAN, L ;
SNYDER, HW ;
BRODEUR, D ;
ZUCKERMAN, EE ;
HARDY, WD .
NATURE, 1986, 320 (6061) :415-421
[6]  
BLECHMAN JM, 1993, J BIOL CHEM, V268, P4399
[7]   ACTIVATION OF THE HUMAN C-KIT PRODUCT BY LIGAND-INDUCED DIMERIZATION MEDIATES CIRCULAR ACTIN REORGANIZATION AND CHEMOTAXIS [J].
BLUMEJENSEN, P ;
CLAESSONWELSH, L ;
SIEGBAHN, A ;
ZSEBO, KM ;
WESTERMARK, B ;
HELDIN, CH .
EMBO JOURNAL, 1991, 10 (13) :4121-4128
[8]   INCREASED KIT/SCF RECEPTOR-INDUCED MITOGENICITY BUT ABOLISHED CELL MOTILITY AFTER INHIBITION OF PROTEIN-KINASE-C [J].
BLUMEJENSEN, P ;
SIEGBAHN, A ;
STABEL, S ;
HELDIN, CH ;
RONNSTRAND, L .
EMBO JOURNAL, 1993, 12 (11) :4199-4209
[9]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[10]   DEVELOPMENTAL ABNORMALITIES IN STEEL(17H) MICE RESULT FROM A SPLICING DEFECT IN THE STEEL FACTOR CYTOPLASMIC TAIL [J].
BRANNAN, CI ;
BEDELL, MA ;
RESNICK, JL ;
EPPIG, JJ ;
HANDEL, MA ;
WILLIAMS, DE ;
LYMAN, SD ;
DONOVAN, PJ ;
JENKINS, NA ;
COPELAND, NG .
GENES & DEVELOPMENT, 1992, 6 (10) :1832-1842